Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The Bentall procedure introduced in 1968 represents an undisputed cure to treat multiple pathologies involving the aortic valve and the ascending thoracic aorta. Over the years, multiple modifications have been introduced as well as a standardized approach to the operation with the goal to prevent long-term adverse events. The Gelweave Valsalva graft provides a novel manner to more efficiently reconstruct the anatomy of the aortic root either with a valve-sparing procedure or with the implantation of a valved conduit (bioprosthesis or mechanical valve). The prosthesis holds three sections: the collar anchoring the valve; the skirt mimicking the Valsalva, which is suitable for the anastomoses with the coronary arteries; and the main body of the graft, which is designed to replace the ascending aorta. The Gelweave Valsalva graft allows the Bentall operation to be standardized, and it provides a potential for longer durability with reduced adverse events.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1615/JLongTermEffMedImplants.2016011509 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Florida sleeve procedure for type II aortic regurgitation with aortic root enlargement: a case report.
Gen Thorac Cardiovasc Surg Cases
February 2024
Division of Cardiovascular Surgery, Department of Cardiovascular Surgery, Tokuyama Central Hospital, Yamaguchi, Japan.
Background: Florida sleeve procedure is an operative technique for aortic root reconstruction that offers advantages such as reduced bleeding risk, shorter operation time, and improved formation of the atrioventricular junction (AVJ) and sinotubular junction (STJ). In our department, we perform a Florida sleeve procedure for aortic regurgitation (AR) associated with aortic root enlargement of less than 40 mm in diameter of the Valsalva sinus. Here, we present a case of severe type II AR with aortic root enlargement where we successfully performed Florida sleeve procedure and augmented it with autologous pericardium.
View Article and Find Full Text PDFLate Pulmonary Autograft Dilation: Can We Make a Good Operation Great? The Supported Ross.
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu
March 2024
Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin; Herma Heart Institute, Children's Wisconsin, Milwaukee, Wisconsin.
The Ross procedure is an excellent option for aortic valve replacement resulting in outstanding hemodynamic performance and the ability to avoid systemic anticoagulation. The long-term durability of the autograft is generally good but concerns for later aortic root dilation with ensuing neoaortic insufficiency have prompted efforts to stabilize the autograft, root, sinuses and Sino-tubular junction in order to delay or entirely avoid late reinterventions on the neoaortic root. We have employed an inclusion technique, supporting the Auto-graft in a Terumo Gelweave™ Valsalva graft.
View Article and Find Full Text PDFModified composite-graft technique for aortic root replacement.
Gen Thorac Cardiovasc Surg
April 2023
Department of Cardiothoracic Surgery, St Vincent's Hospital, Sydney, New South Wales, Australia.
This report describes a novel modification of a self-assembled composite graft to replace the aortic root and left ventricular outflow tract (LVOT). This technique enables the implantation of a larger valve than conventional ways and simultaneous reconstruction of LVOT. This technique comprises Inspiris Resilia aortic valve and Gelweave Valsalva graft.
View Article and Find Full Text PDFSurgical Repair of a Sinus of Valsalva Aneurysm.
World J Pediatr Congenit Heart Surg
November 2022
Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Article Synopsis
- A complex surgical case of an unruptured Sinus of Valsalva aneurysm (SoVA) accompanied by severe aortic regurgitation due to cusp prolapse is discussed.
- The surgical procedure involved reconstructing the sinus using a patch from a Gelweave Valsalva graft.
- To address the inadequate height of the right coronary cusp found during the operation, additional modifications were made by plicating the cusp and augmenting it with a pericardial patch, leading to successful outcomes.
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.
Am Heart J
September 2020
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH.
Vitamin K antagonists are the only approved oral anticoagulants for long-term prophylaxis against valve thrombosis and thromboembolism in patients with a mechanical heart valve. Despite the proven efficacy and safety of anticoagulation with the oral direct factor Xa inhibitor apixaban compared with warfarin in high-risk populations including subjects with atrial fibrillation or with venous thromboembolism, it remains unknown whether patients with a mechanical heart valve can be safely managed with apixaban. The On-X Aortic Heart Valve and On-X Ascending Aortic Prosthesis with the Vascutek Gelweave Valsalva Graft may have lower rates of valve thrombosis and thromboembolism than conventional bileaflet and tilting disc valves due its unique pyrolytic carbon composition and flared inlet design.
View Article and Find Full Text PDF